Doctors

As Big Pharma has risen to power and gained outsized influence within the Medical Establishment a troubling trend has emerged: polypharmacy. Polypharmacy is a situation in which a person is … Continue Reading →

The doctor-patient relationship plays an important role in health outcomes, yet its foundations have shifted significantly in recent decades. With the advent of the internet and digital communication, information about … Continue Reading →

This month’s bulletin covers new imaging technology, novel uses for old drugs, and a potential anti-aging elixir. First, we’ll look at a medical product out of Spain that uses technology … Continue Reading →

A study published in February 2024 in the journal Nature Metabolism drew an association between dietary protein intake and the risk of cardiovascular problems. However, a closer look at the … Continue Reading →

The Food and Drug Administration (FDA) has added its strictest warning to Amgen’s osteoporosis drug Prolia (denosumab). The move comes after years of additional monitoring and testing of a known … Continue Reading →

A recent study has unveiled a new osteoporosis drug under development. However, the direction the researchers are taking closely resembles an existing osteoporosis drug: Evenity (romosozumab). The researchers promote their … Continue Reading →

Today we’ll be tackling one of the most confounding and troubling trends in modern medicine. Scientific studies have confirmed again and again that for many ailments and conditions, dietary changes … Continue Reading →

A study led by the University of Bristol in the UK has found that the mechanism of action of the osteoporosis drug romosozumab (Evenity) increases the risk of heart attack … Continue Reading →

This month’s bulletin covers new studies about the impact of diet on bone health, new medical technologies for assessing fracture risk, and an honest look at how doctors treat their … Continue Reading →